Predictive factors of non-deterioration of glucose tolerance following a 2-year behavioral intervention by Almeida-Pititto, Bianca et al.
RESEARCH Open Access
Predictive factors of non-deterioration of glucose
tolerance following a 2-year behavioral
intervention
Bianca Almeida-Pititto1, Amélia T Hirai2, Daniela S Sartorelli3, Helena A Harima2, Suely GA Gimeno2,
Sandra RG Ferreira1*, the Japanese-Brazilian Diabetes Study Group
Abstract
Aim: To identify predictive factors associated with non-deterioration of glucose metabolism following a 2-year
behavioral intervention in Japanese-Brazilians.
Methods: 295 adults (59.7% women) without diabetes completed 2-year intervention program. Characteristics of
those who maintained/improved glucose tolerance status (non-progressors) were compared with those who
worsened (progressors) after the intervention. In logistic regression analysis, the condition of non-progressor was
used as dependent variable.
Results: Baseline characteristics of non-progressors (71.7%) and progressors were similar, except for the former
being younger and having higher frequency of disturbed glucose tolerance and lower C-reactive protein (CRP). In
logistic regression, non-deterioration of glucose metabolism was associated with disturbed glucose tolerance -
impaired fasting glucose or impaired glucose tolerance - (p < 0.001) and CRP levels ≤ 0.04 mg/dL (p = 0.01),
adjusted for age and anthropometric variables. Changes in anthropometry and physical activity and achievement
of weight and dietary goals after intervention were similar in subsets that worsened or not the glucose tolerance
status.
Conclusion: The whole sample presented a homogeneous behavior during the intervention. Lower CRP levels and
diagnosis of glucose intolerance at baseline were predictors of non-deterioration of the glucose metabolism after a
relatively simple intervention, independent of body adiposity.
Introduction
Several anthropometric and metabolic parameters have
been associated with cardiometabolic risk [1]. More
recently, inflammatory markers have been studied as
predictors of diabetes and cardiovascular events [2].
Japanese-Brazilians are considered as high cardiometa-
bolic risk since they present high prevalence of distur-
bances of glucose metabolism and other cardiovascular
risk factors [3,4]. Environmental factors should contri-
bute to such picture and certain dietary habits were pre-
viously shown to predict metabolic syndrome in this
population [5]. Therefore, a behavioral intervention was
developed in order to improve cardiometabolic profile
of this Japanese-Brazilian population.
Prospective randomized controlled studies have shown
that behavioral interventions targeting diet and physical
activity can delay or prevent the progression from
impaired glucose tolerance (IGT) to diabetes [6-8].
However, the effect of lifestyle intervention varies
among individuals and it would be helpful to identify
those who benefit from an intervention and therefore
should be targeted considering such strategy.
The Diabetes Prevention Study (DPS) showed the base-
line characteristics of individuals who had benefits from
the intervention [9]. However, intensive interventions as
those employed in the DPS might not be feasible in
developing countries. The Japanese-Brazilian Diabetes
Study (JBDS) Group implemented an intervention based
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on lifestyle counseling for diabetes prevention, using
resources tailored to the reality of public health in a
developing country. Preliminary results showed that diet-
ary n-3 fatty acid may predict improvement in glucose
disturbance after the first year of intervention [10].
We investigated the participants who had benefits
from the intervention, maintaining or improving their
glucose tolerance status. The objective of this study was
to identify predictive factors of those who benefit from
the intervention regarding non-deterioration of glucose
tolerance status following 2-year behavioral prevention
program in a developing country. Additionally, we com-
pared lifestyle habits and anthropometry after the inter-
vention of those who improved or maintained glucose
tolerance status with those who worsened it.
Methods
■ Study design
First- (Japan-born) and second-generation (Brazil-born)
Japanese-Brazilians, who participated in the Study on
Diabetes and Associated Diseases in Japanese-Brazilian
Population conducted in 2000, in the city of Bauru
(IDH-M 0.825) [11]; State of Sao Paulo, Brazil, were
invited to join a 2-year non-pharmacological interven-
tion program, started in 2005. The aims and potential
benefits of the behavioral intervention were outlined in
invitation letters and telephone contacts. From a total of
728 who agreed to participate, 413 individuals com-
pleted the intervention. After excluding individuals who
already had a diagnosis of diabetes or were taking hypo-
glycemic medication, 254 participants were included.
Baseline demographic and clinical characteristics of
the participants in 2005 who were lost to follow-up
(n = 315) were similar to those who completed the
2-year intervention (data not shown).
The Institutional Ethics Committee approved the
study protocol and written consent was obtained from
all participants.
■ Intervention
The intervention strategy targeted changes in dietary
intake and levels of physical activity [12], and was based
on a previous trial conducted among overweight Brazi-
lian adults [13]. Participants were scheduled for one
individualized dietary counseling, five group sessions for
nutritional and physical activity recommendation and
two community events of exercise - including walking,
stretching and dancing - during the two-year interven-
tion program. In the individualized dietary counseling
session, participants had a face-to-face one-hour consul-
tation session with a nutritionist (60 days after the first
assessment), during which they received a diet prescrip-
tion with a food exchange list and were encouraged to
practice at least 30 minutes of physical activity every
day. Group sessions included 10 participants and were
coordinated by nutritionists and physical educators. The
relatives of all participants were also invited to take part
in the group sessions. During the group sessions, physi-
cal educators and dietitians reinforced the role of a
healthy lifestyle and discussed the barriers to reaching
the goals of the intervention program.
The dietary recommendation consisted of changes in
total energy intake according to the individual nutritional
status. A low calorie diet was prescribed (restriction of
500 to 1000 calories daily from the estimated total energy
expenditure) for overweight individuals or those with
central obesity but not for normal weight individuals.
The proportions of macronutrients in relation to total
energy intake were 50-60% of carbohydrates; < 30% of
total fat; < 10% of saturated fat; 10-15% of proteins;
< 300 mg of cholesterol and ≥ 15 g of vegetable fibers.
The goals of the intervention were ≥ 5% weight loss
for those with excessive weight, ≥ 150 minutes/week of
physical activities, daily intake < 10% of saturated fat;
daily consumption of ≥ 400 g of fruits and vegetables.
■ Clinical and laboratory procedures
Participants were scheduled for laboratory procedures
and visits with the multi-professional team in the nutri-
tional clinics of the Sagrado Coração University, in the
city of Bauru at baseline and after one and two years of
the intervention program. In each occasion, fasting
blood samples (and also an oral glucose tolerance test
with 75 g of glucose) were obtained for biochemical and
hormonal determinations. Individuals underwent a
detailed medical examination, the International Physical
Activity Questionnaire was applied and 3-day food
records were obtained.
Body weight and height were measured using cali-
brated electronic scales and a fixed rigid stadiometer,
respectively, while participants wore light clothing with-
out shoes. Body mass index (BMI) was calculated as
weight (kilograms) divided by height (meters) squared.
Waist circumference was measured with an inextensible
tape, according to WHO technique [14]. The cutoffs to
diagnose overweight (BMI ≥ 23 kg/m2) and central obe-
sity (abdominal circumference ≥ 80 cm for women and
≥ 90 cm for men) were based on the WHO criteria for
Asian populations [15].
Blood pressure was taken three times using an auto-
matic device (Omron model HEM-712C, Omron Health
Care, Inc, USA), after a five-min rest in sitting position.
Blood pressure was considered as the mean of the sec-
ond and third measurements. Hypertension was diag-
nosed if the systolic blood pressure was ≥ 140 mmHg
and/or diastolic blood pressure ≥ 90 mmHg [16].
Fasting blood samples were taken and a 75 g oral glu-
cose tolerance test performed. Samples were immediately
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centrifuged and analyses made in the local laboratory.
Plasma glucose was measured by the gluco-oxidase
method and lipoproteins enzymatically by automatic ana-
lyser. ADA criteria were used to diagnose diabetes,
impaired fasting glucose (IFG) and impaired glucose tol-
erance (IGT) [17]; the latter two categories were grouped
as glucose intolerance. The diagnosis of dyslipidemia
was based on the National Cholesterol Education
Program [18].
Remaining samples were stored at -80°C prior to hor-
mone and inflammatory markers assay. Insulin was
determined by immunometric assay using a quantitative
chemiluminescent kit (Euro DPC Limited - Glyn
Rhonwy, Llanberis, Caernarfon, Gwynedd, UK), with
analytical sensitivity of 2.0 uIU/mL; intra-assay coeffi-
cient of variability ranged from 5.3% to 6.4% and the
inter-assay coefficient of variability from 5.9% to 8.0%.
Homeostasis model assessment of insulin resistance
(HOMA-IR) was calculated [19]. Adiponectin was mea-
sured by radioimmunoassay (Linco Research Inc, St
Charles, MO, USA). The high sensitivity C-reactive pro-
tein (CRP) was assessed by an immunometric assay with
a quantitative chemiluminescent kit (DPC - Diagnostic
Products Corporation- Los Angeles, USA) with an ana-
lytical sensitivity of 0.01 mg/dL and a functional sensi-
tivity of less than 0.02 mg/dL; the intra-assay coefficient
of variability (CV) ranged from 4.2% to 6.4% and the
inter-assay CV from 4.8% to 10.0%. Interleukin 6 (IL-6)
and tumor necrosis factor-alpha (TNF-a) were deter-
mined by immunometric assay a quantitative chemilu-
minescent kits (Euro DPC Limited - Glyn Rhonwy,
Llanberis, Caernarfon, Gwynedd, UK). Analytical sensi-
tivity of IL-6 was 2.0 pg/mL; its intra-assay CV ranged
from 3.5% to 6.2% and the inter-assay CV from 5.1% to
7.2%. TNF-a analytical sensitivity was 1.7 pg/mL and
intra-assay CV ranged from 2.6% to 3.6% and the inter-
assay CVs from 4.0% to 6.0%.
■ Statistical analysis
Individuals who persisted in their categories of glucose
tolerance or improved (changed from glucose intoler-
ance to normal tolerance) glucose metabolism from
2005 to 2007 were classified as “non-progressors”, and
those who worsened the glucose tolerance status (chan-
ged from normal to glucose intolerance or diabetes and
from glucose intolerance to diabetes) as “progressors”.
Baseline characteristics of the progressors and non-
progressors are presented as qualitative variables
(dichotomized for established cutoffs available or in ter-
tiles) in table 1. Chi-square test was used for compari-
sons between these groups. Variables that showed
statistically differences at the level of p < 0.20 were
entered into a logistic regression model, in which non-
progressor category was the outcome variable. Logistic
regression analysis was performed to identify indepen-
dent predictors of those who benefit from the interven-
tion in terms of glucose tolerance status. The final
model was adjusted for body adiposity, since increased
BMI and abdominal circumference are relevant risk fac-
tors for deterioration of glucose metabolism.
To evaluate if those who benefit from the intervention
in terms of glucose tolerance status had healthier dietary
habits, physical activity or anthropometry after the inter-
vention, we compared the percentages (by chi-square
test) of individuals who succeeded in achieving each of
the four study goals and the mean changes (Student t
test) in abdominal circumference from 2005 to 2007.
Considering the small number of participants achieving
Table 1 Baseline characteristics of participants according
to the progression of glucose metabolism disturbance
Progressors
n = 72
Non-
progressors
n = 182
p
Women 44 (61) 104 (57) 0.56
Age ≥ 60 years 42 (58) 84 (46) 0.08
Increased BMI 36 (50) 104 (57.1) 0.28
Abdominal obesity 45 (62.5) 104 (57.1) 0.46
Hypertension 31 (43) 77 (43.1) 0.91
Glucose metabolism
Normal 47 (65.3) 41 (22.5) <0.001
IFG or IGT 25 (34.7) 141 (77.5)
Dyslipidemia 55 (76.4) 151 (83.0) 0.42
Insulin (uIU/mL)
< 2.3 23 (41.1) 51 (30.0) 0.22
≥ 2.3 to < 4.8 23 (41.1) 73 (42.9)
≥ 4.8 10 (17.9) 46 (27.1)
Adiponectin (ng/mL)
< 5.3 20 (33.2) 58 (33.9) 0.40
≥ 5.3 to < 8.8 17 (28.3) 62 (36.3)
≥ 8.8 23 (38.3) 51 (29.8)
C-reactive protein (mg/dL)
< 0.04 11 (18.6) 49 (28.7) 0.02
≥ 0.04 to < 0.14 18 (30.5) 70 (40.9)
≥ 0.14 30 (50.8) 52 (30.4)
Interleukin-6 (pg/dL)
< 1.8 14 (25.0) 51 (30.2) 0.76
≥ 1.8 to < 2.8 21 (37.5) 58 (34.3)
≥ 2.8 21 (37.5) 60 (35.5)
Tumor necrosis factor-a (pg/
dL)
< 3.6 18 (32.1) 53 (31.4) 0.98
≥ 3.6 to < 6.2 20 (35.7) 59 (34.9)
≥ 6.2 18 (32.1) 57 (33.7)
Data expressed in number of individuals and percentages in parenthesis.
p value from chi-square test.
BMI, body mass index
IFG, impaired fasting glucose
IGT, impaired glucose tolerance
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the goal of physical activity (5% of the whole sample),
we compared the percentage of those who increased
their physical activity at any degree after the interven-
tion (43% of the whole sample).
Sensitivity analyses were conducted excluding those
who were taking and/or changed medications (antihy-
pertensive, lipid lowering or antidiabetic agents) which
might influence outcomes.
Statistical analyses were performed using SPSS 12.0
software (SPSS Inc. Woking, Surrey, UK). Significance
level was set at p < 0.05.
Results
Of 254 non-diabetic participants [mean 59.4 (11.9)
years], 59.7% were women and 83% second-generation
Japanese-Brazilians. Considering their mean values (and
standard deviation) of BMI [24.2 (4.0) kg/m2] and
abdominal circumference [83.9 (9.9) cm for women and
90.1 (10.2) cm for men], they had increased body adip-
osity. After the intervention, there was a slight but sig-
nificant mean (95% confidence interval) reduction in
BMI [-0.3 (-0.2 to -0.4) kg/m2] and in abdominal cir-
cumference [-1.9 (-2.6 to 5.6) cm] in the whole sample.
The most common goal achieved was concerned to the
saturated fat intake; 74.5% consumed less than 10% of
saturated fat of total energy consumed per day. Almost
42% of the individuals reached ≥ 5% weight loss from the
baseline; 39% achieved the goal of fruits and vegetables
intake (> 400 g of per day) and only 7.4% reported to
practice at least 150 minutes of physical activity per
week. Stratifying in progressors and non-progressors,
these proportions did not differ between subsets.
One hundred and three participants had the diagnosis
of IGT or IFG in 2005. The intervention induced higher
mean changes (and standard deviation) in fasting plasma
glucose in individuals with IFG or IGT compared with
those with normal glucose tolerance [- 3.2 (12.3) vs. 0.6
(11.6) mg/dL, respectively, p = 0.02].
A total of 72% (n = 182) of the participants main-
tained or improved their glucose tolerance status (non-
progressors) following the intervention. Baseline
characteristics of the non-progressors and progressors
were similar, except for the higher percentage of indivi-
duals in the age group < 60 years, with glucose intoler-
ance (IFG or IGT) category and in the lower tertiles of
CRP levels (table 1). Looking at the mean values (and
standard deviation) of these variables, the non-progres-
sors had younger age [58.0 (11.7) vs. 61.2 (12.4) years,
p = 0.05], higher fasting plasma glucose [100.7 (11.0) vs.
96.3 (10.5) mg/dL, p = 0.004] and lower CRP levels
[0.20 (0.43) vs. 0.27 (0.38) mg/dL, p = 0.009] compared
with the progressors (data not shown in table).
In the final logistic regression model, the diagnosis
of glucose intolerance (IFG or IGT) and CRP levels
< 0.04 mg/dL at baseline were predictive of non-
deterioration of glucose tolerance following the inter-
vention program, adjusted for age ≥ 60 years (table 2).
The significance of these results did not change when
elevated BMI or abdominal circumference or gender
was entered in the model.
Sensitivity analyses, regarding the use and/or change
in medications, did not change the results.
Discussion
Reducing the high risk of cardiovascular disease among
the Japanese-Brazilian population was the motivation for
this behavioral intervention, which could potentially be
extended into a broader prevention program throughout
the country. In this relatively simple intervention pro-
gram, most of the participants (71.7%) maintained or
improved their glucose tolerance status after the inter-
vention. This study was able to identify baseline charac-
teristics associated with the prevention of the
progression of the natural history of glucose metabolism
disturbances in two years.
Descriptive analysis identified three baseline character-
istics - age ≤ 60 years, presence of glucose intolerance
and CRP levels ≤ 0.04 mg/dL - which differed between
progressors and non-progressors. Those who improved
or maintained glucose tolerance status were younger
than those who deteriorated, but age was not indepen-
dently associated with non-progressor status in logistic
regression. This finding might indicate that age is an
important factor for deterioration of glucose metabo-
lism, but other metabolic characteristics may minimize
the expected effect of aging. According to the multivari-
ate analyses, a lower grade of inflammation (reflected by
the CRP levels) could identify those more prone to ben-
efit from a behavioral intervention in terms of non-
deterioration of glucose tolerance. Also, individuals with
glucose intolerance (IFG or IGT) had a better response
to intervention in terms of glucose tolerance outcome.
Such finding is in agreement with the DPS, in which
Table 2 Estimated odds ratios of non-progression (95%
confidence intervals) in Japanese-Brazilians who
underwent the intervention, obtained from logistic
regression analysis
Odds ratio (95% CI) P value
Age ≥ 60 years 0.50 (0.25-1.21) 0.06
Glucose intolerance* 5.89 (2.85-12.16) <0.001
C-reactive protein
≥ 0.14 1.00
≥ 0.04 to < 0.14 2.1 (0.98-4.60) 0.06
< 0.04 3.3 (1.27-8.66) 0.01
* Includes impaired fasting glucose and impaired glucose tolerance
When abdominal circumference or BMI were entered in the model, the
significant results did not change.
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individuals with more unfavorable baseline diabetes risk
score (FINDRISC) had a higher decrease in diabetes
incidence [9]. This may suggest that the impact of beha-
vioral interventions on cardiometabolic profile is more
pronounced in those with any degree of metabolic dis-
turbances. In fact, a higher decrease in plasma glucose
in these individuals was found when compared to nor-
mal glucose tolerant ones. We speculate that those with
abnormalities of glucose metabolism may be more moti-
vated to modify their lifestyle in order to improve their
health, when submitted to prevention programs.
This finding of lower CRP level at baseline in the non-
progressor group is in the same line of the results from
prospective case-control studies, in which elevated levels
predicted the development of type 2 diabetes, support-
ing a possible role for inflammation in diabetogenesis
[20-23]. In our study, multivariate analysis showed that
CRP levels were inversely and independently associated
with the non-progression status, even adjusted for age,
glucose tolerance status and measurements of adiposity.
Among Japanese Americans, Nakanishi et al also found
that CRP was a risk factor for development of type 2
diabetes, independently of either obesity or insulin resis-
tance [2]. We suggest that the lower levels of CRP
might be indicative of a better prognosis in terms of
metabolic risk.
The goals of our community-based intervention
program were not achieved by the majority of the parti-
cipants. This could be attributed to our approach - tai-
lored to the reality of a developing country - that was
much less intensive than that used in other intervention
trials [6,7]. Similar proportions of progressors and non-
progressors achieved the goals. It means that these goals
should be reflecting mainly the effect of the follow-up
and reinforces the importance of identifying predictors
at baseline. Interestingly, the most commonly achieved
goal was the reduction of saturated fat intake. Consider-
ing previous findings in the same population, regarding
the association of fat intake with metabolic syndrome
[5], such reduction was highly desirable and could have
contribute to the improvement in metabolic profile.
Slight, but significant reduction in anthropometry
occurred following the intervention in the whole sample.
The lack of association of the intervention-induced adip-
osity reduction on glucose metabolism benefits is in
agreement with other studies conducted in Asian popu-
lations. The Indian Diabetes Prevention Program
showed reduced risk of diabetes without any significant
change in anthropometric variables [24]. Another study
based on lifestyle intervention showed a greater reduc-
tion in the incidence of diabetes in Japanese men than
might be expected simply on the basis of the decrease
in BMI [25], suggesting that while weight loss may be
desirable, it does not fully explain the effects of beha-
vioral interventions.
Our study has limitations. The definition of progres-
sors implicates in certain heterogeneity of this group of
individuals, including not only 32 incident cases of dia-
betes, but also those who progressed from normal glu-
cose tolerance to IFG or IGT. Another point to be
observed is that we do not have the data of those indivi-
duals who were lost to follow-up that could implicate in
a selection bias. However, baseline characteristics of the
subset that did not complete the intervention program
did not differ from those who were evaluated at the end
of the intervention. The findings of the present study
cannot be extrapolated to other populations.
In summary, our findings suggest that individuals with
lower CRP levels and with glucose intolerance at base-
line were the ones who will benefit from this relatively
simple intervention in terms of glucose metabolism,
independent of body adiposity. The homogeneous beha-
vior of the whole sample during the intervention period
suggests that the simple fact of being followed-up may
result in favorable changes in glucose tolerance, which
seems relevant in terms of public health for developing
countries.
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